Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $88.6900 (-4.37%) ($88.3400 - $94.4400) on Tue. Oct. 20, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.35% (three month average) | RSI | 43 | Latest Price | $88.6900(-4.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.8% a day on average for past five trading days. | Weekly Trend | LGND declines -2.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(51%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.175% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-14%) UNG(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.175% (StdDev 2.35%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $97.9 | 5 Day Moving Average | $94.92(-6.56%) | 10 Day Moving Average | $98.64(-10.09%) | 20 Day Moving Average | $97.9(-9.41%) | To recent high | -30% | To recent low | 0% | Market Cap | $1.425b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |